nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.644	1	CbGbCtD
Phentermine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00943	0.0692	CbGeAlD
Phentermine—SLC6A4—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0087	0.0699	CbGpPWpGaD
Phentermine—MAOB—nerve—amyotrophic lateral sclerosis	0.00821	0.0603	CbGeAlD
Phentermine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00761	0.0558	CbGeAlD
Phentermine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00706	0.0518	CbGeAlD
Phentermine—MAOA—nerve—amyotrophic lateral sclerosis	0.00701	0.0514	CbGeAlD
Phentermine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00647	0.0475	CbGeAlD
Phentermine—MAOB—hindbrain—amyotrophic lateral sclerosis	0.00615	0.0452	CbGeAlD
Phentermine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00597	0.063	CcSEcCtD
Phentermine—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00525	0.0385	CbGeAlD
Phentermine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00517	0.0546	CcSEcCtD
Phentermine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00493	0.052	CcSEcCtD
Phentermine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0048	0.0506	CcSEcCtD
Phentermine—MAOA—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.00453	0.0363	CbGpPWpGaD
Phentermine—MAOB—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00445	0.0358	CbGpPWpGaD
Phentermine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0448	CcSEcCtD
Phentermine—MAOA—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00414	0.0333	CbGpPWpGaD
Phentermine—SLC6A3—Parkinsons Disease Pathway—ATXN2—amyotrophic lateral sclerosis	0.00409	0.0329	CbGpPWpGaD
Phentermine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00405	0.0297	CbGeAlD
Phentermine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0424	CcSEcCtD
Phentermine—MAOB—embryo—amyotrophic lateral sclerosis	0.00385	0.0282	CbGeAlD
Phentermine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0405	CcSEcCtD
Phentermine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00381	0.0402	CcSEcCtD
Phentermine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00371	0.0272	CbGeAlD
Phentermine—MAOB—brainstem—amyotrophic lateral sclerosis	0.00353	0.0259	CbGeAlD
Phentermine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0035	0.0281	CbGpPWpGaD
Phentermine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0367	CcSEcCtD
Phentermine—MAOA—embryo—amyotrophic lateral sclerosis	0.00328	0.0241	CbGeAlD
Phentermine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00327	0.024	CbGeAlD
Phentermine—MAOA—Oxidative Stress—GSR—amyotrophic lateral sclerosis	0.00317	0.0254	CbGpPWpGaD
Phentermine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00312	0.0229	CbGeAlD
Phentermine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0031	0.0249	CbGpPWpGaD
Phentermine—MAOA—brainstem—amyotrophic lateral sclerosis	0.00301	0.0221	CbGeAlD
Phentermine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00298	0.0315	CcSEcCtD
Phentermine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0311	CcSEcCtD
Phentermine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00285	0.03	CcSEcCtD
Phentermine—MAOA—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00279	0.0224	CbGpPWpGaD
Phentermine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0295	CcSEcCtD
Phentermine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0283	CcSEcCtD
Phentermine—SLC6A4—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00268	0.0216	CbGpPWpGaD
Phentermine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00262	0.0277	CcSEcCtD
Phentermine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0273	CcSEcCtD
Phentermine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00253	0.0267	CcSEcCtD
Phentermine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00252	0.0185	CbGeAlD
Phentermine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0262	CcSEcCtD
Phentermine—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.00246	0.018	CbGeAlD
Phentermine—SLC6A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00243	0.0195	CbGpPWpGaD
Phentermine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0255	CcSEcCtD
Phentermine—SLC6A2—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00231	0.0185	CbGpPWpGaD
Phentermine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00231	0.0169	CbGeAlD
Phentermine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00228	0.0167	CbGeAlD
Phentermine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0237	CcSEcCtD
Phentermine—SLC6A4—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0022	0.0177	CbGpPWpGaD
Phentermine—MAOB—spinal cord—amyotrophic lateral sclerosis	0.00219	0.0161	CbGeAlD
Phentermine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00218	0.023	CcSEcCtD
Phentermine—SLC6A3—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00215	0.0173	CbGpPWpGaD
Phentermine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0226	CcSEcCtD
Phentermine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0226	CcSEcCtD
Phentermine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0224	CcSEcCtD
Phentermine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00212	0.0156	CbGeAlD
Phentermine—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.0021	0.0154	CbGeAlD
Phentermine—SLC6A4—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.00207	0.0167	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00204	0.0164	CbGpPWpGaD
Phentermine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00204	0.015	CbGeAlD
Phentermine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.002	0.0146	CbGeAlD
Phentermine—MAOA—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00199	0.0159	CbGpPWpGaD
Phentermine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0208	CcSEcCtD
Phentermine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0207	CcSEcCtD
Phentermine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00194	0.0143	CbGeAlD
Phentermine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00193	0.0155	CbGpPWpGaD
Phentermine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00187	0.0137	CbGeAlD
Phentermine—MAOA—spinal cord—amyotrophic lateral sclerosis	0.00187	0.0137	CbGeAlD
Phentermine—MAOB—nervous system—amyotrophic lateral sclerosis	0.00185	0.0136	CbGeAlD
Phentermine—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0018	0.0145	CbGpPWpGaD
Phentermine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00179	0.0131	CbGeAlD
Phentermine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0188	CcSEcCtD
Phentermine—MAOB—central nervous system—amyotrophic lateral sclerosis	0.00178	0.0131	CbGeAlD
Phentermine—MAOA—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00177	0.0142	CbGpPWpGaD
Phentermine—MAOB—cerebellum—amyotrophic lateral sclerosis	0.00174	0.0128	CbGeAlD
Phentermine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00171	0.0126	CbGeAlD
Phentermine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0179	CcSEcCtD
Phentermine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00165	0.0121	CbGeAlD
Phentermine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0173	CcSEcCtD
Phentermine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00162	0.0119	CbGeAlD
Phentermine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0166	CcSEcCtD
Phentermine—MAOA—nervous system—amyotrophic lateral sclerosis	0.00158	0.0116	CbGeAlD
Phentermine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0165	CcSEcCtD
Phentermine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0165	CcSEcCtD
Phentermine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0164	CcSEcCtD
Phentermine—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00153	0.0123	CbGpPWpGaD
Phentermine—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00152	0.0111	CbGeAlD
Phentermine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00149	0.0109	CbGeAlD
Phentermine—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00148	0.0109	CbGeAlD
Phentermine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0155	CcSEcCtD
Phentermine—MAOA—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	0.00143	0.0115	CbGpPWpGaD
Phentermine—MAOB—brain—amyotrophic lateral sclerosis	0.00141	0.0104	CbGeAlD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00132	0.0106	CbGpPWpGaD
Phentermine—SLC6A2—brain—amyotrophic lateral sclerosis	0.00131	0.0096	CbGeAlD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00128	0.0103	CbGpPWpGaD
Phentermine—SLC6A3—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.00123	0.00986	CbGpPWpGaD
Phentermine—MAOA—brain—amyotrophic lateral sclerosis	0.0012	0.00884	CbGeAlD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0011	0.00881	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00109	0.00875	CbGpPWpGaD
Phentermine—MAOA—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00109	0.00872	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00108	0.00866	CbGpPWpGaD
Phentermine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000951	0.00763	CbGpPWpGaD
Phentermine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000937	0.00687	CbGeAlD
Phentermine—SLC6A2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000936	0.00752	CbGpPWpGaD
Phentermine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000902	0.00662	CbGeAlD
Phentermine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000881	0.00647	CbGeAlD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000848	0.00681	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000848	0.00681	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000848	0.00681	CbGpPWpGaD
Phentermine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000842	0.00676	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00083	0.00666	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000797	0.0064	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000752	0.00604	CbGpPWpGaD
Phentermine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000716	0.00525	CbGeAlD
Phentermine—SLC6A3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000699	0.00561	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000695	0.00558	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000695	0.00558	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000695	0.00558	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000694	0.00557	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000685	0.0055	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00067	0.00538	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000645	0.00518	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000623	0.005	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000614	0.00493	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000613	0.00492	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000607	0.00488	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000584	0.00469	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000576	0.00463	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00057	0.00458	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00057	0.00458	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00057	0.00458	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00057	0.00458	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000551	0.00442	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000535	0.0043	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000532	0.00427	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00053	0.00425	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00053	0.00425	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000528	0.00424	CbGpPWpGaD
Phentermine—SLC6A3—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.000517	0.00415	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000513	0.00412	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000508	0.00408	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000505	0.00406	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000494	0.00397	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000485	0.00389	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000481	0.00386	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000477	0.00383	CbGpPWpGaD
Phentermine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000472	0.00379	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000472	0.00379	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00047	0.00377	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000468	0.00376	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000449	0.00361	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000439	0.00352	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000437	0.00351	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000437	0.00351	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000436	0.00351	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000432	0.00347	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000429	0.00345	CbGpPWpGaD
Phentermine—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000422	0.00339	CbGpPWpGaD
Phentermine—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000422	0.00339	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000413	0.00332	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000406	0.00326	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000406	0.00326	CbGpPWpGaD
Phentermine—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.0004	0.00321	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000398	0.0032	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000389	0.00313	CbGpPWpGaD
Phentermine—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000386	0.0031	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000383	0.00307	CbGpPWpGaD
Phentermine—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000368	0.00296	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000366	0.00294	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000362	0.0029	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00036	0.00289	CbGpPWpGaD
Phentermine—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000359	0.00288	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000346	0.00277	CbGpPWpGaD
Phentermine—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000337	0.00271	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000336	0.0027	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000333	0.00268	CbGpPWpGaD
Phentermine—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000315	0.00253	CbGpPWpGaD
Phentermine—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000305	0.00245	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00029	0.00233	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000285	0.00229	CbGpPWpGaD
Phentermine—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000265	0.00213	CbGpPWpGaD
Phentermine—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000265	0.00213	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000257	0.00206	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000257	0.00206	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000246	0.00198	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000246	0.00198	CbGpPWpGaD
Phentermine—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000242	0.00194	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000235	0.00188	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000231	0.00186	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000225	0.00181	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00022	0.00176	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000219	0.00176	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000219	0.00176	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000218	0.00175	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000218	0.00175	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000218	0.00175	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000218	0.00175	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000213	0.00171	CbGpPWpGaD
Phentermine—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000212	0.0017	CbGpPWpGaD
Phentermine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000208	0.00167	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000205	0.00165	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000201	0.00161	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000194	0.00156	CbGpPWpGaD
Phentermine—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000191	0.00154	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.00019	0.00152	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000186	0.0015	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000186	0.00149	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00018	0.00144	CbGpPWpGaD
Phentermine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000177	0.00142	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000175	0.00141	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000175	0.00141	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000152	0.00122	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00015	0.00121	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000149	0.0012	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000149	0.0012	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000148	0.00119	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000147	0.00118	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000145	0.00117	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000141	0.00113	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000134	0.00108	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000127	0.00102	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000126	0.00101	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00012	0.000965	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000115	0.000926	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000115	0.000926	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000115	0.000922	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000114	0.000918	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000114	0.000918	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00011	0.000883	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000107	0.000856	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000105	0.000847	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000105	0.000839	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.8e-05	0.000787	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	9.77e-05	0.000784	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	9.77e-05	0.000784	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.72e-05	0.00078	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.42e-05	0.000756	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	9.22e-05	0.00074	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	9.14e-05	0.000734	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.1e-05	0.000731	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.93e-05	0.000717	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.65e-05	0.000695	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	8.33e-05	0.000669	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.3e-05	0.000667	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	8.26e-05	0.000664	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.81e-05	0.000627	CbGpPWpGaD
Phentermine—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	7.12e-05	0.000572	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	7.06e-05	0.000567	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	6.32e-05	0.000507	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	6.26e-05	0.000503	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.91e-05	0.000475	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	5.83e-05	0.000468	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.78e-05	0.000464	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.43e-05	0.000436	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.35e-05	0.00043	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.26e-05	0.000423	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.94e-05	0.000397	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.88e-05	0.000392	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	4.79e-05	0.000384	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.75e-05	0.000381	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.5e-05	0.000361	CbGpPWpGaD
Phentermine—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	4.47e-05	0.000359	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.33e-05	0.000348	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.05e-05	0.000326	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.7e-05	0.000297	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.06e-05	0.000246	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.97e-05	0.000238	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.57e-05	0.000207	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.55e-05	0.000205	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.54e-05	0.000204	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.36e-05	0.00019	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.34e-05	0.000188	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.18e-05	0.000175	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2e-05	0.000161	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.95e-05	0.000156	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.93e-05	0.000155	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.65e-05	0.000132	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.33e-05	0.000107	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.32e-05	0.000106	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-05	9.07e-05	CbGpPWpGaD
